Defense Health Agency (DHA) awards $500,000 to SilkTech to support SDP-4 eye drop analytical test method development work.

SilkTech received a $500,000 SBIR Phase 2 Enhancement award from the DHA. The award will support work to develop bioanalytical and bioassay test methods to support pre-clinical and clinical testing of the SDP-4 eye drop product.